Document is current
Any future updates will be listed below
-
Authors
Zhang, Xuexi
Wang, Hao
Liu, Wenxu
Xiao, Zengtuan
Ma, Zhenyi
Zhang, Zhenfa
Gong, Wenchen
Chen, Jun
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81825017, 81773034, 8217113342, 81872350, 82273119)
Ministry of Science and Technology of the People’s Republic of China (2018YFC1313002)
Tianjin Science and Technology Committee (20JCZDJC00110, 18JCZDJC99100)
- License Information
-
More Information
Article History
Received: 3 February 2022
Revised: 30 November 2022
Accepted: 2 December 2022
First Online: 14 December 2022
Competing interests
: The authors declare no competing interests.
: The use of all human lung cancer tissues was approved by the Institutional Review Board of Tianjin Medical University. Informed consents were obtained from all patients, and samples were deidentified prior to analysis. All animal procedures were approved by the Animal Care and Use Committee at Tianjin Medical University and confirmed to the legal mandates and national guidelines for the care and maintenance of laboratory animals.
